These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33816220)

  • 1. Screening of miRNAs as Prognostic Biomarkers for Colon Adenocarcinoma and Biological Function Analysis of Their Target Genes.
    Zheng G; Zhang G; Zhao Y; Zheng Z
    Front Oncol; 2021; 11():560136. PubMed ID: 33816220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
    Wei HT; Guo EN; Liao XW; Chen LS; Wang JL; Ni M; Liang C
    Oncol Rep; 2018 Oct; 40(4):1947-1958. PubMed ID: 30066920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying a new microRNA signature as a prognostic biomarker in colon cancer.
    Lv Y; Duanmu J; Fu X; Li T; Jiang Q
    PLoS One; 2020; 15(2):e0228575. PubMed ID: 32049961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An 11-Gene Signature Risk-Prediction Model Based on Prognosis-Related miRNAs and Their Target Genes in Lung Adenocarcinoma.
    Zhou N; Zhou M; Ding N; Li Q; Ren G
    Front Oncol; 2021; 11():726742. PubMed ID: 34804921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
    Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
    Gene; 2019 May; 697():86-93. PubMed ID: 30779946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Novel Six-miRNA-Based Model to Predict Overall Survival Among Colon Adenocarcinoma Patients.
    Rong Z; Rong Y; Li Y; Zhang L; Peng J; Zou B; Zhou N; Pan Z
    Front Oncol; 2020; 10():26. PubMed ID: 32154160
    [No Abstract]   [Full Text] [Related]  

  • 7. Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma.
    Li W; Liu S; Su S; Chen Y; Sun G
    PeerJ; 2021; 9():e10470. PubMed ID: 33510968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Transcription Factor-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma.
    Lin J; Cao Z; Yu D; Cai W
    Front Genet; 2021; 12():709133. PubMed ID: 34603375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and validation of a prognostic model based on HRR-related lncRNAs in colon adenocarcinoma.
    Tang X; Lin Y; He J; Luo X; Liang J; Zhu X; Li T
    World J Surg Oncol; 2022 Mar; 20(1):74. PubMed ID: 35264195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
    Xiaoli Z; Yawei W; Lianna L; Haifeng L; Hui Z
    Med Sci Monit; 2015 Dec; 21():3748-59. PubMed ID: 26628405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MicroRNA model that can predict the prognosis of oral squamous cell carcinoma based on bioinformatics analysis].
    Zhao G; Li CX; Guo C; Zhu H
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Dec; 38(6):622-627. PubMed ID: 33377337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening Protein Prognostic Biomarkers for Stomach Adenocarcinoma Based on The Cancer Proteome Atlas.
    Zheng GL; Zhang GJ; Zhao Y; Zheng ZC
    Front Oncol; 2022; 12():901182. PubMed ID: 35574353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A New RBPs-Related Signature Predicts the Prognosis of Colon Adenocarcinoma Patients.
    Chang K; Yuan C; Liu X
    Front Oncol; 2021; 11():627504. PubMed ID: 33767995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer.
    Wang XJ; Zeng B; Lin S; Chen M; Chi P
    Ann Clin Lab Sci; 2019 Nov; 49(6):730-739. PubMed ID: 31882423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a nine-miRNA signature for the prognosis of Uveal Melanoma.
    Xin X; Zhang Y; Ling F; Wang L; Sheng X; Qin L; Zhao X
    Exp Eye Res; 2019 Mar; 180():242-249. PubMed ID: 30615885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs Associated With Colon Cancer: New Potential Prognostic Markers and Targets for Therapy.
    Zhu J; Xu Y; Liu S; Qiao L; Sun J; Zhao Q
    Front Bioeng Biotechnol; 2020; 8():176. PubMed ID: 32211396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis.
    Yang G; Zhang Y; Yang J
    Front Oncol; 2019; 9():1207. PubMed ID: 31799184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of microRNA/mRNA signature in colon adenocarcinoma.
    Wang JY; Wang CL; Wang XM; Liu FJ
    Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2114-2129. PubMed ID: 28537673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics analyses of significant prognostic risk markers for thyroid papillary carcinoma.
    Min XS; Huang P; Liu X; Dong C; Jiang XL; Yuan ZT; Mao LF; Chang S
    Tumour Biol; 2015 Sep; 36(10):7457-63. PubMed ID: 25908172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a five-microRNA signature as a prognostic biomarker for esophageal squamous cell carcinoma.
    Yu J; Zhu M; Lv M; Wu X; Zhang X; Zhang Y; Li J; Zhang Q
    Sci Rep; 2019 Dec; 9(1):19847. PubMed ID: 31882677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.